Tell us about your organization

 
 

Tell us about you

Work Email required

Organization required

First Name required

Last Name required

Job Title required

Phone required (###) ###-####, or int ######...

City required

State/Province required

Business Information

error messages will go here...

Looks like we’re already familiar with you!

Please press next to continue with the survey.

Looks like we’re already familiar with you!

According to your account type you are not eligible to take surveys at this time. If this is a mistake, please contact KLAS.

If you are trying to access KLAS research data and reports, an email has been sent to   with a link to login.

If the email doesn't appear in your inbox, ask your IT department to add KLASresearch.com to your company spam filter's "whitelist", and check your email's spam folder.

Membership Commitment

In exchange for giving their feedback, healthcare providers can create an account to get access to industry reports, user commentary, and real-time ratings.

By submitting your account request, you are engaged in patient care as either an employee (or contractor) of your provider organization and that you confirm that you have reviewed and agree to abide by the Terms of Use for this website as updated periodically.

To learn more about how we process and protect your personal data, you may view our Privacy policy.

By submitting your account request, you confirm that you have reviewed and agree to abide by the Terms of Use for this website as updated periodically. To learn more about how we process and protect your personal data, you may view our Privacy policy.

By submitting your account request, you confirm that you have reviewed and agree to abide by the Terms of Use for this website as updated periodically.

To learn more about how we process and protect your personal data, you may view our Privacy policy.

 

To learn more about how we process and protect your personal data, you may view our Privacy policy.

 

To learn more about how we process and protect your personal data, you may view our Privacy policy.

Thank You! Your information was submitted successfully!

Next Steps - An email has been sent to . Please follow its instructions to verify your email, and login.

If the email doesn't appear in your inbox, try asking your IT department to add KLASresearch.com to your company spam filter's "whitelist", and checking your email's spam folder.

Thank You! Your information was submitted successfully!

Next Steps - A KLAS representative will contact you to discuss working with KLAS, typically within 24 to 48 hours.

If you have any further questions please contact info@klasresearch.com or 1-800-920-4109.

Surprise! Looks like we already have an account for you.

An email has been sent to blah@blah.com with a link to login.

If the email doesn't appear in your inbox, try asking your IT department to add KLASresearch.com to your company spam filter's "whitelist", and checking your email's spam folder.

Thank you !

Access info about on your dashboard or bookmark under

(Your Products / Your Organization's Products)

VigiLanz

Headquarters:

Minneapolis Minnesota, United States

Sector Funding:

Go to Website

VigiLanz's Current COVID-19 Response and Solutions

The following information was supplied by the vendor and has not been validated by KLAS.

COVID-19 alerts
Alerts for real-time case identification

VigiLanz’s team of Certified Infection Preventionists is proactively providing alerts for real-time case identification as well as additional targeted support, including:

  • Syndromic screening for COVID-like illnesses. VigiLanz monitors vitals, imaging, and notes to identify possible patients who have not tested positive, yet need to be isolated.
  • Identify all patients being screened, as well as positive patients. VigiLanz can enable alerts for patients that have testing ordered, alerts for all results related to COVID-19, and/or for COVID-19 positive tests. Customization is based on the needs of the infection preventionists at the facility.
  • Identify patients who are at high risk, and identify clusters of the disease. VigiLanz has rules to identify high-risk patients that can be deployed in circumstances like this. VigiLanz also has the ability to alert IPs when clusters of specific organisms occur.
  • Identify opportunities to change medications from those that are in short supply related to COVID-19. VigiLanz can alert frontline pharmacists when specific medications are ordered to help limit their use.
  • Identify patients that were missed through all other means of screening and identification (the “swiss-cheese model”). VigiLanz has rules that leverage ICD-10 billing codes specific to coronavirus to help ensure that any missed patients are identified to limit further exposures.
  • Understand the current COVID-19 burden on healthcare systems. Reports including data on admissions, testing, ICU utilization, ventilator utilization, medication utilization, etc. provide system-wide insight.
  • Manage the impact of COVID-I9 on employees. Work up employee exposures, furlough needs, testing, and disease acquisition in the outbreak tools.

Best in KLAS Awards


Thank you !

Access info about on your dashboard or bookmark under

(Your Products / Your Organization's Products)

Software Overall Score Data collected between Jan 2020 - Jan 2021

92.3

 Product
Segment
 

Exceptions

R
Regional Classification
C
Component Products
S
Superseded Products
NP
Not Primary Products
DR
Data Review
MS
Limited Market Share
FR
Data frozen, live data no longer collected.

The following exceptions refer to the number of unique organizations contributing evaluations to the overall score (minimum of 15 required).

# of Unique Organization Evaluations:

0 - 5
L 6 - 14

Segment Position

Segment positions refer to the order in which this product is scored among competitors’ products within its market segment.

In order to be scored in a segment, the product must have sufficient data levels and be equivalent in scope to other products within that segment.

Click the segment positions listed below to learn more.